Nusano
  • Home
  • Company
    • Leadership
    • West Valley City
  • Technology
  • News
  • Careers
  • Contact Us
Select Page
Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

by Scott Larrivee | May 1, 2023 | News

Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah

Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah

by Scott Larrivee | Apr 17, 2023 | News, Utah

New domestic supply source to help address critical shortage of medical radioisotopes   Proprietary platform will be capable of generating up to 12 different rare isotopes simultaneously WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping...

Recent Posts

  • Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
  • Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
  • Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day
  • Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals
  • Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Recent Comments

No comments to show.
Supplying the fight against cancer.
  • Follow
Company
about us
Leadership
Contact us
technology
Proprietary tech
Applications
Investors
Resources
News
Careers
Suppliers
© 2023 Nusano | Web design
Privacy Policy – Terms of Service